Prospective Cohort Study of CLinical and Imaging Patterns of NeUroinflammation DisEases (CLUE)

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

CLUE is a prospective study to determine structural and functional changes of brain and spinal cord, as well as the inflammatory environment in patients with neuroinflammatory and demyelination disease. Participants will receive new magnetic resonance (MR) technics including double inversion recovery (DIR) imaging diffusion kurtosis imaging (DKI), quantitative susceptibility mapping (QSM) and resting-state functional imaging and follow up for one year using 3T MRI. In addition, participants will receive T1WI, T2WI, FLAIR and SWI sequences on 7T MRI.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 75
Healthy Volunteers: t
View:

• 16-75

• Diagnosis of neuroinflammatory and demyelination disease

• Availability of demographic and clinical data at the time disease onset

• Informed written consent obtained from the patient, and/or patient's parent(s), and/or legal representative. Assent, if old enough to grant, will be obtained from all patients under the age of 16 years.

Locations
Other Locations
China
Beijing Tiantan Hospital
RECRUITING
Beijing
Contact Information
Primary
Yaou Liu, PhD
yaouliu80@163.com
+86 1059975396
Time Frame
Start Date: 2019-01-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1000
Treatments
NMOSD
Patients with neuromyelitis optica spectrum disorders
Multiple sclerosis(MS)
Patients with multiple sclerosis
MOGAD
Patients with myelin oligodendrocyte glycoprotein antibody-associated disease
Healthy controls (HC)
Healthy people without any neuroinflammation disease
Sponsors
Leads: Beijing Tiantan Hospital

This content was sourced from clinicaltrials.gov